about
Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression.Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers.Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs.Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment.Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort.Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression.Association of genetic risk scores with body mass index in Swiss psychiatric cohorts.Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic Treatments.Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.Influence of CRTC1 polymorphisms on body mass index and fat mass in psychiatric patients and the general adult population.Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain.Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs.Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia.[New developments in psychiatry].Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients
P50
Q35804713-AAD8CF4E-8EF6-46AE-962E-5C3A18711E5CQ39291645-5658554C-6EB2-44CC-BB79-D3ADB79BBC2AQ40128463-7C400D62-1E51-4050-AC2D-07E2780F7B48Q40233499-89652794-BB02-4E30-A945-BE10683F41ADQ40780592-267F290D-1F09-4932-8745-7E44468BA1D9Q40839651-591FB28D-0E23-47D3-8338-888438D87F96Q40885533-1DBA8B05-FEEE-41E7-969D-B4B04EC7D485Q41476590-1EB44CAA-7E63-4A77-ACD0-9728803D3DC9Q44916931-06666631-C978-4676-AF12-F486E9270A5DQ45352082-11FA92D8-5791-45B4-9767-20631352EC52Q47172445-CFFC4BDA-1B5B-4651-B48C-9AC8AC092857Q47186097-C518CF12-8734-4BB6-A058-7F7CA3925E37Q47613572-BAA4D25B-5D6D-466B-9BF4-1DA4B3FE963FQ50250053-036A33D0-AB3C-48C5-B3E5-A3A4F31BF003Q89155133-A3517694-0D7C-48BD-AD25-139C21477BF2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Frederik Vandenberghe
@ast
Frederik Vandenberghe
@en
Frederik Vandenberghe
@es
Frederik Vandenberghe
@nl
Frederik Vandenberghe
@sl
type
label
Frederik Vandenberghe
@ast
Frederik Vandenberghe
@en
Frederik Vandenberghe
@es
Frederik Vandenberghe
@nl
Frederik Vandenberghe
@sl
prefLabel
Frederik Vandenberghe
@ast
Frederik Vandenberghe
@en
Frederik Vandenberghe
@es
Frederik Vandenberghe
@nl
Frederik Vandenberghe
@sl
P106
P21
P31
P496
0000-0002-8964-2047